2 July 2019

The Dutch Cancer Society (KWF) has awarded 25.5 million euros to 50 new research projects in 16 different institutes. 8 grants are awarded to Radboudumc researchers. We congratulate our researchers with this funding and wish them success with their great work.

Research projects:

Research project: Immunotherapy meets Radiotherapy: understanding cGAS to define immunogenic vs non‐immunogenic radiation conditions
Gosse Adema, theme Cancer development and immune defense, RIMLS
Approved budget: € 580,756

Research project: Metastases-directed therapy for PET detected oligo-recurrent prostate cancer with and without short course androgen deprivation therapy
Robert Jan Smeenk / Fred Verzijlbergen, theme Urological cancers, RIHS
Approved budget: € 899,591

Research project: Dissecting the role of aberrant E-cadherin signaling in the initiation and progression of diffuse-type gastric cancer.
Chella van der Post, theme Tumors of the digestive tract, RIMLS
Approved budget: € 653,075

Research project: (Cost) Effectiveness of Blended and UnguideD DeliverY of Mindfulness‐based Cognitive Therapy versus Care as Usual for distressed cancer patients: BUDDY project
Anne Speckens, theme Stress related disorders, DCMN
Approved budget: € 494,505

Research project: Identification of genetic cancer predisposition through tumour genome mutational profiling
Richarda de Voer, theme Tumors of the digestive tract, RIMLS
Approved budget: € 566,411

Research project: Induction of neo-antigen specific T cells by specialised cross-presenting dendritic cells in epithelial ovarian cancer patients
Jolanda de Vries, theme Cancer development and immune defense, RIMLS
Approved budget: € 657,575
 

Young Investigator grant:

Research project: Imaging tumor infiltrating CD8+ T‐cells in non‐small cell lung cancer patients
Erik Aarntzen, theme Tumors of the digestive tract, RIMLS
Approved budget: € 365,732 


Consortium grant

Research project: The phospho proteome, key to derailed kinases in intestinal tumors and customized therapy
Henk Verheul, theme Tumors of the digestive tract
Approved budget: € 1,091,077

Go to the Dutch Cancer Society website (KWF).

 

Related news items


The Postdoctoral Networking Tour in artificial intelligence

2 July 2020

You are a postdoctoral researcher in the field of artificial intelligence? The Postdoc-NeT-AI offers you the opportunity to participate in one week of on-site visits to leading German universities, research institutes and companies. Apply now to this year's tour until 16 August 2020.

read more

Register for Phd courses via gROW What does this mean for you?

2 July 2020

From now on you can arrange everything related to the general RU PhD courses via gROW. Because of this there will be some changes in the registration! What does this mean for you?

read more

Experts on metabolic diseases still an unknown major problem...

1 July 2020

Six Dutch UMCs and a patient association contribute to treating and solving this major, often unknown, problem. Timely detection of metabolic diseases is vital. Therefore, Radboudumc is also part of the consortium “United for Metabolic Diseases”.

read more

Radboud Pluim for Lionne Ekers ambassador for the RIMLS institute

30 June 2020

Lionne Ekers received the Radboudpluim for her special merits for the Radboudumc. She is a born ambassador for our Institute.

read more

Stefan Listl member Lancet Commission on Oral Health

29 June 2020

In recognition of the global public health importance, woeful neglect of oral diseases, and the need for a broader understanding and commitment to global oral health within medicine and global health agendas, The Lancet recently established a Commission on Oral Health.

read more

Trained immunity: a tool for reducing susceptibility to and the severity of SARS-CoV-2 infection

29 June 2020

In a review in Cell Mihai Netea, Frank van de Veerdonk, Reinout van Crevel and Jorge Dominguez Andres propose that induction of trained immunity by whole-microorganism vaccines may represent an important tool for reducing susceptibility to and severity of SARS-CoV-2.

read more